期刊
ISCIENCE
卷 24, 期 3, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.isci.2021.102135
关键词
-
资金
- Science and Engineering Research Board (SERB), Department of Science AMP
- Technology, Ministry of Science and Technology, MinisGovernment of India [SB/S1/Covid-2/2020]
- IRCC, IIT Bombay [RD/0520-IRCCHC0-006]
- MASSFIIT (Mass Spectrometry Facility, IIT Bombay) from the Department of Biotechnology [BT/PR13114/INF/22/206/2015]
- CSIR-SRF funding
- IIT Bombay-IPDF funding
This study conducted a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19, identifying some host proteins that were upregulated in COVID-19-positive patients, and important pathways that provide detailed insights into the host response in COVID-19 infection. Additionally, the docking of potential drugs with host proteins involved in the interleukin-12 signaling pathway may aid in COVID-19 therapeutic interventions.
The altered molecular proteins and pathways in response to COVID-19 infection are still unclear. Here, we performed a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19 to study the host response by employing simple extraction strategies. Few of the host proteins such as interleukin-6, L-lactate dehydrogenase, C-reactive protein, Ferritin, and aspartate aminotransferase were found to be upregulated only in COVID-19-positive patients using targeted multiple reaction monitoring studies. The most important pathways identified by enrichment analysis were neutrophil degranulation, interleukin-12 signaling pathways, and mRNA translation of proteins thus providing the detailed investigation of host response in COVID-19 infection. Thus, we conclude that mass spectrometry-detected host proteins have a potential for disease severity progression; however, suitable validation strategies should be deployed for the clinical translation. Furthermore, the in silico docking of potential drugs with host proteins involved in the interleukin-12 signaling pathway might aid in COVID-19 therapeutic interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据